Clinical Studies

Pillar objectives Pillar 3 aims to develop an advanced approach for accelerating clinical testing, focusing on flexible trial operations and innovative study designs. This includes trial decentralization, overlapping seamless trials, and template clinical trial protocols with regulatory and ethical review institutions. WP10 Phase I/II clinical studies (Lead: UA; Partners involved: Inserm, LUMC, KUM, UK [...]